×
Loyola University Chicago Logo Loyola University Chicago Stritch School of Medicine Department of Medicine

Hematology & Oncology

The Division of Hematology & Oncology is the driving force behind the Cardinal Bernardin Cancer Center, the second largest cancer center in Illinois.

Faculty have expertise in several clinical areas but are very active in Loyola University Medical Center's Graduate Medical Education programs. They teach and/or lead various courses and lectures for the hematology/oncology fellows in our ACGME Accredited Hematology/Oncology Fellowship Program, Loyola University Medical Center residents, and Stritch School of Medicine medical students. The faculty also participates at annual board reviews, grand rounds, and a variety of Continuing Medical Education (CME) programs.  

Fellowship Program

The fellowship program of the Division of Hematology & Oncology is a three-year training program, culminating in dual ABIM board eligibility. Our aim is to produce superior subspecialists who are prepared for careers in academic medicine or community practice.

The Medical Oncology training emphasizes methods of diagnosis; staging, management and treatment of solid tumors through rotations on the inpatient oncology consult service, outpatient subspecialty clinics, and infusion center experiences. The Hematology training focuses on coagulation, hematologic malignancies, anemias, hemoglobinopathies, and disorders of leukocytes and platelets. This is achieved with rotations on the inpatient BMT-ICU service and hematology consult service. To round out the fellowship, elective rotations are available in Radiation Oncology, Gynecologic Oncology, Hematopathology, Blood Bank, Palliative Care, Community Practice, and our High Dose Therapy Unit for post-transplant or post-induction care of hematologic malignancies.

Hematology/Oncology Fellows are expected to be involved in research endeavors relevant to this subspecialty. Opportunities in basic science research, translational research, and clinical research, are plentiful. Additional areas of academic activities expected of fellows include quality improvement projects and medical education of medicine residents and medical students.

Program Director: Nina Undevia Yedavalli, MD, MPH

Associate Program Director: Kirk Cahill, MD

Research

The Division of Hematology & Oncology faculty are actively involved in research on many levels, from basic science to translational to clinical research. We have nationally funded physician scientists and basic scientists with whom we collaborate.  Loyola has been a long time member institution of the Southwest Oncology Group (SWOG), a national cooperative group committed to practice changing clinical research in hematology/oncology.  All cooperative group trials are available through the National Clinical Trials Network (NCTN).  Investigator initiated trials and pharmaceutical-sponsored clinical trials are integral components of our research portfolio as well.

Faculty

Joseph Clark, MD

Professor of Medicine

Eugene Ahn, MD

Assistant Professor

Andrea Amico, MD

Assistant Professor

Kathy S. Albain, MD

Professor of Medicine

Nirav Antao, DO

Assistant Professor

Kevin Barton, MD

Professor of Medicine

Leela Bhupalam, MD

Assistant Professor

Kirk Cahill, MD

Assistant Professor

Patrick Hagen, MD

Associate Professor of Medicine

May Hashimi, MD

Assistant Professor of Medicine

Kathleen Kennedy, MD

Assistant Professor

Jorgena Kosti- Schwartz, DO

Assistant Professor

Imran Puthawala, MD

Assistant Professor

Nan Sethakorn, MD

Assistant Professor of Medicine

Stephanie Tsai, MD

Assistant Professor

Jennifer Weiss, MD

Assistant Professor

Nina Yedavalli, MD

Assistant Professor of Medicine

The Division of Hematology & Oncology is the driving force behind the Cardinal Bernardin Cancer Center, the second largest cancer center in Illinois.

Faculty have expertise in several clinical areas but are very active in Loyola University Medical Center's Graduate Medical Education programs. They teach and/or lead various courses and lectures for the hematology/oncology fellows in our ACGME Accredited Hematology/Oncology Fellowship Program, Loyola University Medical Center residents, and Stritch School of Medicine medical students. The faculty also participates at annual board reviews, grand rounds, and a variety of Continuing Medical Education (CME) programs.  

Fellowship Program

The fellowship program of the Division of Hematology & Oncology is a three-year training program, culminating in dual ABIM board eligibility. Our aim is to produce superior subspecialists who are prepared for careers in academic medicine or community practice.

The Medical Oncology training emphasizes methods of diagnosis; staging, management and treatment of solid tumors through rotations on the inpatient oncology consult service, outpatient subspecialty clinics, and infusion center experiences. The Hematology training focuses on coagulation, hematologic malignancies, anemias, hemoglobinopathies, and disorders of leukocytes and platelets. This is achieved with rotations on the inpatient BMT-ICU service and hematology consult service. To round out the fellowship, elective rotations are available in Radiation Oncology, Gynecologic Oncology, Hematopathology, Blood Bank, Palliative Care, Community Practice, and our High Dose Therapy Unit for post-transplant or post-induction care of hematologic malignancies.

Hematology/Oncology Fellows are expected to be involved in research endeavors relevant to this subspecialty. Opportunities in basic science research, translational research, and clinical research, are plentiful. Additional areas of academic activities expected of fellows include quality improvement projects and medical education of medicine residents and medical students.

Program Director: Nina Undevia Yedavalli, MD, MPH

Associate Program Director: Kirk Cahill, MD

Research

The Division of Hematology & Oncology faculty are actively involved in research on many levels, from basic science to translational to clinical research. We have nationally funded physician scientists and basic scientists with whom we collaborate.  Loyola has been a long time member institution of the Southwest Oncology Group (SWOG), a national cooperative group committed to practice changing clinical research in hematology/oncology.  All cooperative group trials are available through the National Clinical Trials Network (NCTN).  Investigator initiated trials and pharmaceutical-sponsored clinical trials are integral components of our research portfolio as well.